Comparative chemical genomics reveal that the spiroindolone antimalarial KAE609 (Cipargamin) is a P-type ATPase inhibitor. [electronic resource]
Producer: 20180515Description: 27806 p. digitalISSN:- 2045-2322
- Amino Acid Sequence
- Antimalarials -- chemistry
- Binding Sites
- CRISPR-Cas Systems -- genetics
- Cytosol -- chemistry
- Drug Resistance, Fungal
- Indoles -- chemistry
- Inhibitory Concentration 50
- Molecular Docking Simulation
- P-type ATPases -- antagonists & inhibitors
- Plasmodium falciparum -- drug effects
- Protein Structure, Tertiary
- Proton-Translocating ATPases -- antagonists & inhibitors
- Protozoan Proteins -- antagonists & inhibitors
- Saccharomyces cerevisiae -- drug effects
- Saccharomyces cerevisiae Proteins -- antagonists & inhibitors
- Sequence Alignment
- Sequence Analysis, DNA
- Spiro Compounds -- chemistry
- Structure-Activity Relationship
- Whole Genome Sequencing
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.